Providing comprehensive and mature assisted reproductive services, it has become a leading provider of assisted reproductive medical services in China and the US, and has been successfully listed on the Hong Kong Stock Exchange in 2019. The company has three hospitals, located in Chengdu, Shenzhen and California respectively. At present, it accounts for 3.9% and 2.5% share of the assisted reproductive market in China and the US, ranking second and third, respectively.
© SINCE 2020 TIANFU GROUP, ALL RIGHTS RESERVED. 沪ICP备16033206号-1 Powered by Yongsy
